1. Home /
  2. Healthcare

Healthcare

Prognosis Not Quite Clear for AMN Healthcare

Prognosis Not Quite Clear for AMN Healthcare

MN looks like it could move higher and rally, but the uneven trading pattern tells me to look for easier set-ups.

Walmart Climbs on Analysts' Price-Target Increases

Walmart Climbs on Analysts' Price-Target Increases

The stock of the world's biggest retailer is advancing. Several analysts increased their price targets after the company beat Wall Street's second-quarter-earnings expectations.

Care.com Jumps as Activist Investor Urges Review of Strategic Alternatives

Care.com Jumps as Activist Investor Urges Review of Strategic Alternatives

Care.com jumped after Engine Capital urged the online caregiving marketplace to explore strategic alternatives while it searches for a new CEO.

Novocure's Charts Are as Bullish As They Get, So Here's My Strategy

Novocure's Charts Are as Bullish As They Get, So Here's My Strategy

The oncology company has had a strong run and all the technical signals indicate the move higher isn't over.

The Most Valuable American Brands in 2019

The Most Valuable American Brands in 2019

Good branding works - that's why these companies dominate their industries.

Amgen Climbs After Winning Patent Case on Enbrel

Amgen Climbs After Winning Patent Case on Enbrel

Amgen's patents for Enbrel likely to be protected until 2029.

Humana Shares Get Upgrade From Cantor Fitzgerald

Humana Shares Get Upgrade From Cantor Fitzgerald

Humana's larger strategic investments in 'population health management' and the 'social determinants of health' will boost growth over the long-term, Cantor Fitzgerald noted Monday as it upgraded its outlook on the health insurer's stock to overweight.

The Charts of Tandem Diabetes Are Probably Headed Higher With This Subtle Clue

The Charts of Tandem Diabetes Are Probably Headed Higher With This Subtle Clue

The market potential for TNDM is even greater worldwide.

Cardinal Health Climbs After Topping Fourth-Quarter Estimates

Cardinal Health Climbs After Topping Fourth-Quarter Estimates

The healthcare provider posts fiscal fourth-quarter earnings of $1.11 a share, well above analysts' expectations.

Bausch Health Is Struggling to Go Sideways - Risk of Being Long

Bausch Health Is Struggling to Go Sideways - Risk of Being Long

Let's review the charts and indicators of BHC.